Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare
Avalo Therapeutics Inc. Revenue 2015–2025
Avalo Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Avalo Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Avalo Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 249000, a 98.47% decrease year-over-year.
- Avalo Therapeutics Inc. annual revenue for 2025 was 59000, a 86.62% decrease from 2024.
- Avalo Therapeutics Inc. annual revenue for 2024 was 441000, a 77.08% decrease from 2023.
- Avalo Therapeutics Inc. annual revenue for 2023 was 1.9 M, a 89.34% decrease from 2022.
- Avalo Therapeutics Inc. annual revenue for 2022 was 18.1 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avalo Therapeutics Inc. Market Cap — FAQ
Avalo Therapeutics Inc. (AVTX) market cap over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTX's market cap history?
The chart and table above show Avalo Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.